nodes	percent_of_prediction	percent_of_DWPC	metapath
Pethidine—GRIN2A—melanoma	0.48	0.864	CbGaD
Pethidine—ORM1—Vemurafenib—melanoma	0.139	0.489	CbGbCtD
Pethidine—ALB—melanoma	0.0759	0.136	CbGaD
Pethidine—ALB—Vemurafenib—melanoma	0.0585	0.206	CbGbCtD
Pethidine—CYP3A4—Temozolomide—melanoma	0.0335	0.118	CbGbCtD
Pethidine—CYP2D6—Vemurafenib—melanoma	0.0288	0.101	CbGbCtD
Pethidine—CYP3A4—Vemurafenib—melanoma	0.0183	0.0644	CbGbCtD
Pethidine—CYP3A4—Docetaxel—melanoma	0.00629	0.0221	CbGbCtD
Pethidine—Fibrosis—Carmustine—melanoma	0.00218	0.0517	CcSEcCtD
Pethidine—Paralysis—Vemurafenib—melanoma	0.00169	0.0402	CcSEcCtD
Pethidine—Induration—Bleomycin—melanoma	0.00159	0.0378	CcSEcCtD
Pethidine—Neurotoxicity—Docetaxel—melanoma	0.00103	0.0245	CcSEcCtD
Pethidine—Paranoia—Carmustine—melanoma	0.000913	0.0217	CcSEcCtD
Pethidine—Injection site pain—Carmustine—melanoma	0.000762	0.0181	CcSEcCtD
Pethidine—Coordination abnormal—Carmustine—melanoma	0.000633	0.015	CcSEcCtD
Pethidine—Coordination abnormal—Temozolomide—melanoma	0.000612	0.0145	CcSEcCtD
Pethidine—Depressed level of consciousness—Carmustine—melanoma	0.000601	0.0143	CcSEcCtD
Pethidine—Phlebitis—Bleomycin—melanoma	0.0006	0.0143	CcSEcCtD
Pethidine—Depressed level of consciousness—Temozolomide—melanoma	0.00058	0.0138	CcSEcCtD
Pethidine—Disorientation—Bleomycin—melanoma	0.000578	0.0137	CcSEcCtD
Pethidine—Coma—Carmustine—melanoma	0.000568	0.0135	CcSEcCtD
Pethidine—Phlebitis—Dactinomycin—melanoma	0.00056	0.0133	CcSEcCtD
Pethidine—Phlebitis—Carmustine—melanoma	0.000524	0.0124	CcSEcCtD
Pethidine—Erythema—Vemurafenib—melanoma	0.000514	0.0122	CcSEcCtD
Pethidine—Affect lability—Temozolomide—melanoma	0.000429	0.0102	CcSEcCtD
Pethidine—Anaphylactic shock—Vemurafenib—melanoma	0.00042	0.00996	CcSEcCtD
Pethidine—Mood swings—Temozolomide—melanoma	0.000413	0.00982	CcSEcCtD
Pethidine—Hypotension—Vemurafenib—melanoma	0.000392	0.00931	CcSEcCtD
Pethidine—Decreased appetite—Vemurafenib—melanoma	0.000365	0.00866	CcSEcCtD
Pethidine—Constipation—Vemurafenib—melanoma	0.000359	0.00852	CcSEcCtD
Pethidine—Lightheadedness—Docetaxel—melanoma	0.000358	0.00849	CcSEcCtD
Pethidine—Phlebitis—Docetaxel—melanoma	0.000337	0.008	CcSEcCtD
Pethidine—Flushing—Bleomycin—melanoma	0.000332	0.00789	CcSEcCtD
Pethidine—Erythema—Bleomycin—melanoma	0.000312	0.0074	CcSEcCtD
Pethidine—Hallucination—Carmustine—melanoma	0.000311	0.00738	CcSEcCtD
Pethidine—Flushing—Dactinomycin—melanoma	0.00031	0.00735	CcSEcCtD
Pethidine—Hypersensitivity—Vemurafenib—melanoma	0.000309	0.00734	CcSEcCtD
Pethidine—Visual disturbance—Docetaxel—melanoma	0.000306	0.00727	CcSEcCtD
Pethidine—Asthenia—Vemurafenib—melanoma	0.000301	0.00715	CcSEcCtD
Pethidine—Visual impairment—Carmustine—melanoma	0.000301	0.00715	CcSEcCtD
Pethidine—Hallucination—Temozolomide—melanoma	0.0003	0.00713	CcSEcCtD
Pethidine—Pruritus—Vemurafenib—melanoma	0.000297	0.00705	CcSEcCtD
Pethidine—Visual impairment—Temozolomide—melanoma	0.000291	0.00691	CcSEcCtD
Pethidine—Erythema—Dactinomycin—melanoma	0.000291	0.0069	CcSEcCtD
Pethidine—Flushing—Carmustine—melanoma	0.00029	0.00688	CcSEcCtD
Pethidine—Flushing—Temozolomide—melanoma	0.00028	0.00665	CcSEcCtD
Pethidine—Dizziness—Vemurafenib—melanoma	0.000277	0.00659	CcSEcCtD
Pethidine—Erythema—Carmustine—melanoma	0.000272	0.00646	CcSEcCtD
Pethidine—Vomiting—Vemurafenib—melanoma	0.000267	0.00634	CcSEcCtD
Pethidine—Orthostatic hypotension—Docetaxel—melanoma	0.000265	0.00629	CcSEcCtD
Pethidine—Rash—Vemurafenib—melanoma	0.000265	0.00628	CcSEcCtD
Pethidine—Dermatitis—Vemurafenib—melanoma	0.000264	0.00628	CcSEcCtD
Pethidine—Headache—Vemurafenib—melanoma	0.000263	0.00624	CcSEcCtD
Pethidine—Erythema—Temozolomide—melanoma	0.000263	0.00624	CcSEcCtD
Pethidine—Confusional state—Bleomycin—melanoma	0.000256	0.00609	CcSEcCtD
Pethidine—Tremor—Carmustine—melanoma	0.000255	0.00605	CcSEcCtD
Pethidine—Anaphylactic shock—Bleomycin—melanoma	0.000254	0.00604	CcSEcCtD
Pethidine—Oedema—Bleomycin—melanoma	0.000254	0.00604	CcSEcCtD
Pethidine—Agitation—Carmustine—melanoma	0.00025	0.00593	CcSEcCtD
Pethidine—Nausea—Vemurafenib—melanoma	0.000249	0.00592	CcSEcCtD
Pethidine—Tremor—Temozolomide—melanoma	0.000246	0.00585	CcSEcCtD
Pethidine—Anorexia—Bleomycin—melanoma	0.000242	0.00575	CcSEcCtD
Pethidine—Agitation—Temozolomide—melanoma	0.000241	0.00573	CcSEcCtD
Pethidine—Hypotension—Bleomycin—melanoma	0.000238	0.00564	CcSEcCtD
Pethidine—Oedema—Dactinomycin—melanoma	0.000237	0.00563	CcSEcCtD
Pethidine—Vertigo—Temozolomide—melanoma	0.000236	0.00561	CcSEcCtD
Pethidine—Convulsion—Carmustine—melanoma	0.000236	0.00559	CcSEcCtD
Pethidine—Hypertension—Carmustine—melanoma	0.000235	0.00557	CcSEcCtD
Pethidine—Palpitations—Temozolomide—melanoma	0.000232	0.00551	CcSEcCtD
Pethidine—Anxiety—Carmustine—melanoma	0.000231	0.00548	CcSEcCtD
Pethidine—Convulsion—Temozolomide—melanoma	0.000228	0.00541	CcSEcCtD
Pethidine—Hypertension—Temozolomide—melanoma	0.000227	0.00539	CcSEcCtD
Pethidine—Anorexia—Dactinomycin—melanoma	0.000226	0.00537	CcSEcCtD
Pethidine—Confusional state—Carmustine—melanoma	0.000224	0.00531	CcSEcCtD
Pethidine—Anxiety—Temozolomide—melanoma	0.000223	0.00529	CcSEcCtD
Pethidine—Oedema—Carmustine—melanoma	0.000222	0.00527	CcSEcCtD
Pethidine—Decreased appetite—Bleomycin—melanoma	0.000221	0.00525	CcSEcCtD
Pethidine—Dry mouth—Temozolomide—melanoma	0.000219	0.0052	CcSEcCtD
Pethidine—Tachycardia—Carmustine—melanoma	0.000217	0.00514	CcSEcCtD
Pethidine—Confusional state—Temozolomide—melanoma	0.000216	0.00513	CcSEcCtD
Pethidine—Anaphylactic shock—Temozolomide—melanoma	0.000214	0.00509	CcSEcCtD
Pethidine—Oedema—Temozolomide—melanoma	0.000214	0.00509	CcSEcCtD
Pethidine—Anorexia—Carmustine—melanoma	0.000212	0.00502	CcSEcCtD
Pethidine—Feeling abnormal—Bleomycin—melanoma	0.00021	0.00497	CcSEcCtD
Pethidine—Hypotension—Carmustine—melanoma	0.000207	0.00492	CcSEcCtD
Pethidine—Hyperhidrosis—Temozolomide—melanoma	0.000207	0.00492	CcSEcCtD
Pethidine—Decreased appetite—Dactinomycin—melanoma	0.000206	0.00489	CcSEcCtD
Pethidine—Anorexia—Temozolomide—melanoma	0.000204	0.00485	CcSEcCtD
Pethidine—Urticaria—Bleomycin—melanoma	0.000202	0.0048	CcSEcCtD
Pethidine—Insomnia—Carmustine—melanoma	0.000201	0.00477	CcSEcCtD
Pethidine—Somnolence—Carmustine—melanoma	0.000197	0.00468	CcSEcCtD
Pethidine—Feeling abnormal—Dactinomycin—melanoma	0.000195	0.00464	CcSEcCtD
Pethidine—Insomnia—Temozolomide—melanoma	0.000194	0.00461	CcSEcCtD
Pethidine—Visual impairment—Docetaxel—melanoma	0.000193	0.00459	CcSEcCtD
Pethidine—Decreased appetite—Carmustine—melanoma	0.000193	0.00458	CcSEcCtD
Pethidine—Somnolence—Temozolomide—melanoma	0.000191	0.00453	CcSEcCtD
Pethidine—Constipation—Carmustine—melanoma	0.00019	0.00451	CcSEcCtD
Pethidine—Hypersensitivity—Bleomycin—melanoma	0.000187	0.00445	CcSEcCtD
Pethidine—Decreased appetite—Temozolomide—melanoma	0.000186	0.00443	CcSEcCtD
Pethidine—Flushing—Docetaxel—melanoma	0.000186	0.00442	CcSEcCtD
Pethidine—Constipation—Temozolomide—melanoma	0.000183	0.00435	CcSEcCtD
Pethidine—Feeling abnormal—Carmustine—melanoma	0.000183	0.00434	CcSEcCtD
Pethidine—Asthenia—Bleomycin—melanoma	0.000182	0.00433	CcSEcCtD
Pethidine—Pruritus—Bleomycin—melanoma	0.00018	0.00427	CcSEcCtD
Pethidine—Feeling abnormal—Temozolomide—melanoma	0.000177	0.0042	CcSEcCtD
Pethidine—Erythema—Docetaxel—melanoma	0.000175	0.00415	CcSEcCtD
Pethidine—Hypersensitivity—Dactinomycin—melanoma	0.000175	0.00415	CcSEcCtD
Pethidine—Urticaria—Temozolomide—melanoma	0.00017	0.00405	CcSEcCtD
Pethidine—Asthenia—Dactinomycin—melanoma	0.00017	0.00404	CcSEcCtD
Pethidine—Muscle spasms—Docetaxel—melanoma	0.000168	0.00399	CcSEcCtD
Pethidine—Hypersensitivity—Carmustine—melanoma	0.000164	0.00388	CcSEcCtD
Pethidine—Vomiting—Bleomycin—melanoma	0.000162	0.00384	CcSEcCtD
Pethidine—Rash—Bleomycin—melanoma	0.00016	0.00381	CcSEcCtD
Pethidine—Dermatitis—Bleomycin—melanoma	0.00016	0.0038	CcSEcCtD
Pethidine—Asthenia—Carmustine—melanoma	0.000159	0.00378	CcSEcCtD
Pethidine—Hypersensitivity—Temozolomide—melanoma	0.000158	0.00375	CcSEcCtD
Pethidine—Syncope—Docetaxel—melanoma	0.000157	0.00372	CcSEcCtD
Pethidine—Palpitations—Docetaxel—melanoma	0.000154	0.00367	CcSEcCtD
Pethidine—Asthenia—Temozolomide—melanoma	0.000154	0.00365	CcSEcCtD
Pethidine—Loss of consciousness—Docetaxel—melanoma	0.000154	0.00365	CcSEcCtD
Pethidine—Pruritus—Temozolomide—melanoma	0.000152	0.0036	CcSEcCtD
Pethidine—Convulsion—Docetaxel—melanoma	0.000151	0.0036	CcSEcCtD
Pethidine—Nausea—Bleomycin—melanoma	0.000151	0.00359	CcSEcCtD
Pethidine—Hypertension—Docetaxel—melanoma	0.000151	0.00358	CcSEcCtD
Pethidine—Vomiting—Dactinomycin—melanoma	0.000151	0.00358	CcSEcCtD
Pethidine—Rash—Dactinomycin—melanoma	0.00015	0.00355	CcSEcCtD
Pethidine—Dizziness—Carmustine—melanoma	0.000147	0.00348	CcSEcCtD
Pethidine—Dry mouth—Docetaxel—melanoma	0.000145	0.00345	CcSEcCtD
Pethidine—Confusional state—Docetaxel—melanoma	0.000144	0.00341	CcSEcCtD
Pethidine—Anaphylactic shock—Docetaxel—melanoma	0.000143	0.00339	CcSEcCtD
Pethidine—Oedema—Docetaxel—melanoma	0.000143	0.00339	CcSEcCtD
Pethidine—Dizziness—Temozolomide—melanoma	0.000142	0.00337	CcSEcCtD
Pethidine—Vomiting—Carmustine—melanoma	0.000141	0.00335	CcSEcCtD
Pethidine—Nausea—Dactinomycin—melanoma	0.000141	0.00334	CcSEcCtD
Pethidine—Shock—Docetaxel—melanoma	0.00014	0.00333	CcSEcCtD
Pethidine—Rash—Carmustine—melanoma	0.00014	0.00332	CcSEcCtD
Pethidine—Dermatitis—Carmustine—melanoma	0.00014	0.00332	CcSEcCtD
Pethidine—Tachycardia—Docetaxel—melanoma	0.000139	0.00331	CcSEcCtD
Pethidine—Headache—Carmustine—melanoma	0.000139	0.0033	CcSEcCtD
Pethidine—Vomiting—Temozolomide—melanoma	0.000136	0.00324	CcSEcCtD
Pethidine—Anorexia—Docetaxel—melanoma	0.000136	0.00323	CcSEcCtD
Pethidine—Rash—Temozolomide—melanoma	0.000135	0.00321	CcSEcCtD
Pethidine—Dermatitis—Temozolomide—melanoma	0.000135	0.00321	CcSEcCtD
Pethidine—Headache—Temozolomide—melanoma	0.000134	0.00319	CcSEcCtD
Pethidine—Hypotension—Docetaxel—melanoma	0.000133	0.00316	CcSEcCtD
Pethidine—Nausea—Carmustine—melanoma	0.000132	0.00313	CcSEcCtD
Pethidine—Insomnia—Docetaxel—melanoma	0.000129	0.00306	CcSEcCtD
Pethidine—Nausea—Temozolomide—melanoma	0.000127	0.00302	CcSEcCtD
Pethidine—Somnolence—Docetaxel—melanoma	0.000127	0.00301	CcSEcCtD
Pethidine—Decreased appetite—Docetaxel—melanoma	0.000124	0.00294	CcSEcCtD
Pethidine—Constipation—Docetaxel—melanoma	0.000122	0.0029	CcSEcCtD
Pethidine—Feeling abnormal—Docetaxel—melanoma	0.000118	0.00279	CcSEcCtD
Pethidine—Hypersensitivity—Docetaxel—melanoma	0.000105	0.00249	CcSEcCtD
Pethidine—Asthenia—Docetaxel—melanoma	0.000102	0.00243	CcSEcCtD
Pethidine—Pruritus—Docetaxel—melanoma	0.000101	0.0024	CcSEcCtD
Pethidine—Dizziness—Docetaxel—melanoma	9.43e-05	0.00224	CcSEcCtD
Pethidine—Vomiting—Docetaxel—melanoma	9.07e-05	0.00215	CcSEcCtD
Pethidine—Rash—Docetaxel—melanoma	8.99e-05	0.00214	CcSEcCtD
Pethidine—Dermatitis—Docetaxel—melanoma	8.98e-05	0.00213	CcSEcCtD
Pethidine—Headache—Docetaxel—melanoma	8.93e-05	0.00212	CcSEcCtD
Pethidine—Nausea—Docetaxel—melanoma	8.47e-05	0.00201	CcSEcCtD
Pethidine—CYP2B6—Metabolism—SLC5A5—melanoma	6.47e-06	5.53e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—SLC6A11—melanoma	6.43e-06	5.5e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PIP4K2A—melanoma	6.43e-06	5.5e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CD86—melanoma	6.42e-06	5.49e-05	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—CXCL8—melanoma	6.42e-06	5.49e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—VCAN—melanoma	6.38e-06	5.45e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—EDN1—melanoma	6.37e-06	5.45e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—HIF1A—melanoma	6.28e-06	5.37e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—MTAP—melanoma	6.25e-06	5.35e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—GNAQ—melanoma	6.25e-06	5.34e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—CD44—melanoma	6.25e-06	5.34e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—FGF1—melanoma	6.23e-06	5.32e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CSF2—melanoma	6.23e-06	5.32e-05	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—IL2—melanoma	6.13e-06	5.25e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—E2F1—melanoma	6.09e-06	5.21e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—PIK3CB—melanoma	6.06e-06	5.19e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	6.03e-06	5.16e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PDGFRA—melanoma	6.03e-06	5.16e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—KDR—melanoma	6.01e-06	5.14e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—CYP17A1—melanoma	5.99e-06	5.12e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—CYP1B1—melanoma	5.99e-06	5.12e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—ITGB3—melanoma	5.97e-06	5.1e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PRKCA—melanoma	5.97e-06	5.1e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	5.91e-06	5.05e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—VCAN—melanoma	5.86e-06	5.01e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—SPP1—melanoma	5.85e-06	5.01e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MAP2K2—melanoma	5.84e-06	4.99e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—CXCL8—melanoma	5.83e-06	4.98e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—melanoma	5.82e-06	4.98e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—FN1—melanoma	5.78e-06	4.94e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—GNA11—melanoma	5.66e-06	4.84e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—PIK3CB—melanoma	5.66e-06	4.84e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—NOTCH1—melanoma	5.66e-06	4.84e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PHGDH—melanoma	5.57e-06	4.77e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—LUM—melanoma	5.57e-06	4.77e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—IL2—melanoma	5.57e-06	4.76e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—TERT—melanoma	5.55e-06	4.75e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CD80—melanoma	5.54e-06	4.74e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—FASN—melanoma	5.54e-06	4.74e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—RAC1—melanoma	5.53e-06	4.73e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PIK3CG—melanoma	5.53e-06	4.73e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—KIT—melanoma	5.53e-06	4.73e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—APC—melanoma	5.53e-06	4.73e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—NRAS—melanoma	5.53e-06	4.73e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—EGF—melanoma	5.47e-06	4.68e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—HPSE—melanoma	5.47e-06	4.68e-05	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—AKT1—melanoma	5.47e-06	4.67e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—SLC5A5—melanoma	5.45e-06	4.66e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CYP17A1—melanoma	5.38e-06	4.6e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CUBN—melanoma	5.37e-06	4.59e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—HIF1A—melanoma	5.31e-06	4.54e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	5.3e-06	4.54e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—MAPK3—melanoma	5.3e-06	4.53e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—GNAQ—melanoma	5.26e-06	4.5e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—CD44—melanoma	5.26e-06	4.5e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	5.24e-06	4.48e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—BRAF—melanoma	5.2e-06	4.45e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—IL2—melanoma	5.2e-06	4.44e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—SDHD—melanoma	5.18e-06	4.43e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CSPG4—melanoma	5.18e-06	4.43e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—BSG—melanoma	5.18e-06	4.43e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	5.15e-06	4.41e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PTGS2—melanoma	5.1e-06	4.36e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GNA11—melanoma	5.08e-06	4.34e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—KDR—melanoma	5.08e-06	4.34e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—IGF1—melanoma	5.07e-06	4.33e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—CYP1B1—melanoma	5.04e-06	4.31e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—MAPK1—melanoma	5.04e-06	4.31e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—EGFR—melanoma	5.04e-06	4.31e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GPAM—melanoma	5.02e-06	4.29e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—FASN—melanoma	4.97e-06	4.25e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CYP17A1—melanoma	4.95e-06	4.23e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—ABCB1—melanoma	4.93e-06	4.22e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MAP2K1—melanoma	4.9e-06	4.19e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—SLC5A5—melanoma	4.89e-06	4.18e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—FN1—melanoma	4.89e-06	4.18e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PIK3CD—melanoma	4.86e-06	4.16e-05	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—PIK3CA—melanoma	4.82e-06	4.12e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—NOTCH1—melanoma	4.78e-06	4.09e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—KRAS—melanoma	4.76e-06	4.07e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GNAQ—melanoma	4.72e-06	4.04e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CD44—melanoma	4.72e-06	4.04e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CD80—melanoma	4.68e-06	4.01e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—KIT—melanoma	4.68e-06	4e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PIK3CG—melanoma	4.68e-06	4e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—APC—melanoma	4.68e-06	4e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—NRAS—melanoma	4.68e-06	4e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GNA11—melanoma	4.67e-06	4e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—FGF2—melanoma	4.66e-06	3.98e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	4.62e-06	3.95e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—EGF—melanoma	4.62e-06	3.95e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	4.58e-06	3.92e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—FASN—melanoma	4.57e-06	3.91e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PRKCA—melanoma	4.54e-06	3.88e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CYP1B1—melanoma	4.53e-06	3.87e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—ERCC2—melanoma	4.5e-06	3.85e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—SLC5A5—melanoma	4.5e-06	3.85e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—MAPK3—melanoma	4.48e-06	3.83e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PTEN—melanoma	4.45e-06	3.81e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—VEGFA—melanoma	4.42e-06	3.78e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—BRAF—melanoma	4.39e-06	3.76e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—PIK3CA—melanoma	4.37e-06	3.74e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—NRAS—melanoma	4.36e-06	3.73e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MDM2—melanoma	4.36e-06	3.73e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GNAQ—melanoma	4.34e-06	3.71e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CD44—melanoma	4.34e-06	3.71e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—ERBB2—melanoma	4.3e-06	3.67e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—IGF1—melanoma	4.28e-06	3.66e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PLA2G6—melanoma	4.27e-06	3.65e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—MAPK1—melanoma	4.26e-06	3.64e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—EGFR—melanoma	4.26e-06	3.64e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PIK3CB—melanoma	4.24e-06	3.63e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—MAPK3—melanoma	4.18e-06	3.57e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CYP1B1—melanoma	4.16e-06	3.56e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—ABCB1—melanoma	4.15e-06	3.55e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MAP2K1—melanoma	4.14e-06	3.54e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PIK3CD—melanoma	4.11e-06	3.51e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CXCL8—melanoma	4.07e-06	3.48e-05	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—PIK3CA—melanoma	4.07e-06	3.48e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—HRAS—melanoma	4.05e-06	3.46e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—KRAS—melanoma	4.02e-06	3.44e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	4e-06	3.42e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CDKN1B—melanoma	3.98e-06	3.4e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—MAPK1—melanoma	3.97e-06	3.4e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—FGF2—melanoma	3.94e-06	3.37e-05	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—AKT1—melanoma	3.94e-06	3.37e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CASP3—melanoma	3.9e-06	3.33e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—IL2—melanoma	3.89e-06	3.33e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—IL6—melanoma	3.87e-06	3.31e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—VCAN—melanoma	3.83e-06	3.28e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PRKCA—melanoma	3.82e-06	3.27e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CCND1—melanoma	3.8e-06	3.25e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—ERCC2—melanoma	3.79e-06	3.24e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CTNNB1—melanoma	3.76e-06	3.21e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—KRAS—melanoma	3.75e-06	3.21e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—ABCB1—melanoma	3.73e-06	3.19e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—PIK3CA—melanoma	3.7e-06	3.16e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MMP9—melanoma	3.68e-06	3.15e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MDM2—melanoma	3.68e-06	3.15e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CDKN1A—melanoma	3.67e-06	3.14e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PTEN—melanoma	3.66e-06	3.13e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—NFKB1—melanoma	3.65e-06	3.12e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—ERBB2—melanoma	3.63e-06	3.1e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PIK3CB—melanoma	3.58e-06	3.06e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—AKT1—melanoma	3.57e-06	3.06e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PIK3CG—melanoma	3.56e-06	3.04e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—PIK3CA—melanoma	3.45e-06	2.95e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CXCL8—melanoma	3.44e-06	2.94e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PPARG—melanoma	3.43e-06	2.94e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PRKCA—melanoma	3.43e-06	2.93e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—ABCB1—melanoma	3.43e-06	2.93e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—HRAS—melanoma	3.42e-06	2.93e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—ERCC2—melanoma	3.4e-06	2.91e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CDKN1B—melanoma	3.36e-06	2.88e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—TP53—melanoma	3.34e-06	2.85e-05	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—AKT1—melanoma	3.33e-06	2.84e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—VEGFA—melanoma	3.31e-06	2.83e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CASP3—melanoma	3.3e-06	2.82e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—IL2—melanoma	3.29e-06	2.81e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—STAT3—melanoma	3.28e-06	2.8e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—IL6—melanoma	3.27e-06	2.8e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—NRAS—melanoma	3.27e-06	2.79e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CYP17A1—melanoma	3.23e-06	2.77e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CCND1—melanoma	3.21e-06	2.74e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—HRAS—melanoma	3.19e-06	2.73e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CTNNB1—melanoma	3.18e-06	2.72e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PRKCA—melanoma	3.16e-06	2.7e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.14e-06	2.69e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—ERCC2—melanoma	3.13e-06	2.68e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MAPK3—melanoma	3.13e-06	2.68e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PIK3CD—melanoma	3.13e-06	2.67e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MMP9—melanoma	3.11e-06	2.66e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CDKN1A—melanoma	3.1e-06	2.65e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PTEN—melanoma	3.1e-06	2.65e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—ALB—melanoma	3.09e-06	2.64e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—NFKB1—melanoma	3.08e-06	2.63e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GNA11—melanoma	3.05e-06	2.61e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MYC—melanoma	3.04e-06	2.6e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—AKT1—melanoma	3.02e-06	2.58e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PIK3CG—melanoma	2.99e-06	2.56e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—FASN—melanoma	2.99e-06	2.56e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MAPK1—melanoma	2.98e-06	2.55e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—EGFR—melanoma	2.98e-06	2.55e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—SLC5A5—melanoma	2.94e-06	2.51e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PPARG—melanoma	2.89e-06	2.47e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GNAQ—melanoma	2.84e-06	2.43e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CD44—melanoma	2.84e-06	2.43e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.82e-06	2.41e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—AKT1—melanoma	2.82e-06	2.41e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—KRAS—melanoma	2.81e-06	2.41e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—VEGFA—melanoma	2.8e-06	2.39e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—STAT3—melanoma	2.77e-06	2.37e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—NRAS—melanoma	2.76e-06	2.36e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PIK3CB—melanoma	2.73e-06	2.33e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CYP1B1—melanoma	2.72e-06	2.33e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PTGS2—melanoma	2.7e-06	2.31e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PIK3CG—melanoma	2.69e-06	2.3e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MAPK3—melanoma	2.65e-06	2.26e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PIK3CD—melanoma	2.63e-06	2.25e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PPARG—melanoma	2.59e-06	2.22e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PIK3CA—melanoma	2.58e-06	2.21e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MYC—melanoma	2.57e-06	2.2e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MAPK1—melanoma	2.52e-06	2.15e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—EGFR—melanoma	2.52e-06	2.15e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—TP53—melanoma	2.5e-06	2.14e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PIK3CG—melanoma	2.47e-06	2.11e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—HRAS—melanoma	2.39e-06	2.04e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PPARG—melanoma	2.39e-06	2.04e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—KRAS—melanoma	2.38e-06	2.03e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PIK3CD—melanoma	2.36e-06	2.02e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PTEN—melanoma	2.35e-06	2.01e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—ALB—melanoma	2.33e-06	1.99e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PIK3CB—melanoma	2.29e-06	1.96e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—IL6—melanoma	2.29e-06	1.96e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PTGS2—melanoma	2.27e-06	1.94e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ABCB1—melanoma	2.24e-06	1.92e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PIK3CA—melanoma	2.18e-06	1.87e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PIK3CD—melanoma	2.17e-06	1.86e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—ALB—melanoma	2.15e-06	1.83e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—TP53—melanoma	2.11e-06	1.81e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—AKT1—melanoma	2.11e-06	1.81e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PRKCA—melanoma	2.06e-06	1.76e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PIK3CB—melanoma	2.06e-06	1.76e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ERCC2—melanoma	2.05e-06	1.75e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PTGS2—melanoma	2.04e-06	1.74e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—HRAS—melanoma	2.02e-06	1.73e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PTEN—melanoma	1.98e-06	1.7e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—IL6—melanoma	1.93e-06	1.65e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PIK3CB—melanoma	1.89e-06	1.62e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PTGS2—melanoma	1.88e-06	1.6e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—AKT1—melanoma	1.78e-06	1.53e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PTEN—melanoma	1.78e-06	1.52e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PIK3CA—melanoma	1.66e-06	1.42e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PTEN—melanoma	1.64e-06	1.4e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PIK3CG—melanoma	1.62e-06	1.38e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PPARG—melanoma	1.56e-06	1.33e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PIK3CD—melanoma	1.42e-06	1.21e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ALB—melanoma	1.4e-06	1.2e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PIK3CA—melanoma	1.4e-06	1.2e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—AKT1—melanoma	1.36e-06	1.16e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PIK3CA—melanoma	1.26e-06	1.07e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PIK3CB—melanoma	1.24e-06	1.06e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PTGS2—melanoma	1.23e-06	1.05e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PIK3CA—melanoma	1.15e-06	9.87e-06	CbGpPWpGaD
Pethidine—ALB—Metabolism—AKT1—melanoma	1.14e-06	9.77e-06	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PTEN—melanoma	1.07e-06	9.15e-06	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—AKT1—melanoma	1.03e-06	8.77e-06	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—AKT1—melanoma	9.43e-07	8.07e-06	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PIK3CA—melanoma	7.55e-07	6.46e-06	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—AKT1—melanoma	6.17e-07	5.27e-06	CbGpPWpGaD
